<?xml version="1.0" encoding="UTF-8"?>
<p>Third, effective therapy, once discovered, must be delivered to an infected person’s home. In the age of Amazon.com, this goal is achievable. Indeed, the Seattle flu study recently pioneered home delivery of baloxavir for early influenza treatment in a clinical trial [
 <xref rid="CIT0031" ref-type="bibr">31</xref>]. Alternatively, a specialized clinic staffed by well trained providers with optimal PPE, as well as those seroimmune to infection, could be established for intravenous infusions. The ongoing Antibody Mediated Prevention study for HIV, in which more than 40 000 doses of a neutralizing antibody or placebo have been infused in 4 continents, highlights the plausibility of such an intervention [
 <xref rid="CIT0032" ref-type="bibr">32</xref>].
</p>
